Mini Review
Accepted on 12 Feb 2026
Metal-based compounds and Chagas Disease treatment: current knowledge and therapeutic perspectives
in Anti-Infective Agents
Frontiers in Drug Discovery
Type at least 3 characters
34 articles
articles
Mini Review
Published on 11 Feb 2026
Standardization of canine infections for the development of antileishmanial drugs
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2026.1754269
- 366 views
Original Research
Published on 17 Sep 2025
Influence of divalent metal ions on gelation of a short heterochiral peptide
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1673051
- 1,421 views
Review
Published on 16 Oct 2024
Metal-antimicrobial peptides combo: promising weapons to combat bacteria invaders
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1440378
- 4,691 views
- 8 citations
Review
Published on 06 Sep 2024
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1458057
- 5,878 views
- 7 citations
Review
Published on 17 Jul 2024
Alternative therapeutics to control antimicrobial resistance: a general perspective
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1385460
- 19,050 views
- 47 citations
Review
Published on 08 Mar 2024
Molecular determinant deciphering of MIC-guided RND efflux substrates in E. coli
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2024.1326121
- 4,939 views
- 4 citations
Editorial
Published on 08 Dec 2023
Editorial: Drug discovery for emerging and neglected tropical diseases: advances, challenges and perspectives
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1346042
- 2,074 views
- 1 citation
Review
Published on 01 Dec 2023
Latest development of approved COVID-19 drugs and COVID-19 drugs undergoing late stage clinical trials
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1304129
- 5,163 views
- 7 citations
Editorial
Published on 23 Nov 2023
Editorial: Advances in anti-malarial drug discovery
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1335842
- 2,257 views
- 2 citations
Original Research
Published on 14 Nov 2023
In vitro drug interaction of ionophores with artemisinin and chloroquine against Plasmodium falciparum 3D7 blood-stage infection
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1257698
- 2,739 views
- 1 citation
Review
Published on 13 Jul 2023
Targeting proteases and proteolytic processing of unusual N-terminal extensions of Plasmodium proteins: parasite peculiarity
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1223140
- 2,925 views
- 3 citations
Original Research
Published on 15 Jun 2023
MMV006087 is a potent Malaria Box compound against Plasmodium falciparum clinical parasites
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1190471
- 3,483 views
- 2 citations
Review
Published on 01 Jun 2023
Lessons that can be learned from the SARS-CoV-2 pandemic and their impact on the prophylaxis and treatment development for neglected tropical arboviruses
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1176768
- 5,690 views
Review
Published on 10 May 2023
The critical role of mode of action studies in kinetoplastid drug discovery
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1185679
- 4,559 views
- 11 citations
Editorial
Published on 27 Feb 2023
Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1157688
- 1,711 views
- 2 citations
Original Research
Published on 10 Feb 2023
HMM-based profiling identifies the binding to divalent cations and nucleotides as common denominators of suramin targets
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1112992
- 2,476 views
Brief Research Report
Published on 05 Jan 2023
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1082065
- 4,560 views
- 8 citations
Review
Published on 07 Dec 2022
The landscape of nature-derived antimalarials-potential of marine natural products in countering the evolving Plasmodium
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.1065231
- 5,165 views
- 8 citations
Original Research
Published on 21 Oct 2022
A machine learning-based virtual screening for natural compounds capable of inhibiting the HIV-1 integrase
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.954911
- 6,759 views
- 12 citations
Original Research
Published on 20 Oct 2022
From drugs to targets: Reverse engineering the virtual screening process on a proteomic scale
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.969983
- 7,116 views
- 13 citations
Review
Published on 12 Oct 2022
Chemically induced phenotypes during the blood stage development of Plasmodium falciparum as indicators of the drug mode of action
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.920850
- 6,946 views
- 6 citations
Original Research
Published on 23 Sep 2022
Integrating diverse layers of omic data to identify novel drug targets in Listeria monocytogenes
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.969415
- 3,493 views
- 7 citations
Original Research
Published on 31 Aug 2022
Bismuth subsalicylate as potential treatment for Covid-19 pneumonia: A case series report
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.962988
- 18,815 views